Q3 2025 13F Holders as of 9/30/2025
-
Type / Class
-
Equity / Class A ordinary share, par value $0.0001
-
Shares outstanding
-
17.3M
-
Number of holders
-
7
-
Total 13F shares, excl. options
-
1.51M
-
Shares change
-
-882K
-
Total reported value, excl. options
-
$15.8M
-
Value change
-
-$9.09M
-
Number of buys
-
1
-
Number of sells
-
-3
-
Price
-
$10.40
Significant Holders of Translational Development Acquisition Corp. - Class A ordinary share, par value $0.0001 (TDACU) as of Q3 2025
9 filings reported holding TDACU - Translational Development Acquisition Corp. - Class A ordinary share, par value $0.0001 as of Q3 2025.
Translational Development Acquisition Corp. - Class A ordinary share, par value $0.0001 (TDACU) has 7 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.51M shares
of 17.3M outstanding shares and own 8.74% of the company stock.
Largest 9 shareholders include Alberta Investment Management Corp (600K shares), Calamos Advisors LLC (375K shares), D. E. Shaw & Co., Inc. (350K shares), RIVERNORTH CAPITAL MANAGEMENT, LLC (100K shares), Yakira Capital Management, Inc. (60K shares), FLOW TRADERS U.S. LLC (15.8K shares), UBS Group AG (8.33K shares), TWO SIGMA INVESTMENTS, LP (0 shares), and MMCAP International Inc. SPC (0 shares).
This table shows the top 7 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.